BioCentury | Mar 25, 2021
Management Tracks

Slaoui resigns from Vaxcyte, Centessa; plus moves at HHS, Fate, Inotrem, Immuneering, SwanBio and more

...sexual harassment allegations, former Operation Warp Speed leader Moncef Slaoui has resigned as chairman of Vaxcyte Inc....
...Services Fate Therapeutics Inc. Cue Health Inc. Inotrem S.A. Harpoon Therapeutics Inc. MatriSys Bioscience Inc. Immuneering Corp. SiteOne Therapeutics Inc. Follicum AB Centessa Pharmaceuticals Ltd. Vaxcyte Inc....
BioCentury | Mar 25, 2021
Management Tracks

Slaoui stepping back from all biopharma roles, expresses ‘deep regrets’ following sexual harassment claim

...years, is a partner at Medicxi and chairman of Medicxi portfolio companies Divide & Conquer and Vaxcyte Inc....
BioCentury | Jan 22, 2021
Product Development

Slaoui on Warp Speed’s successes, limitations and lessons

...in 2016 by GSK and Verily Life Sciences to develop and commercialize bioelectronic medicines, and SutroVax...
...to have platform trials running as quickly as possible. Steve Usdin GlaxoSmithKline plc Pfizer Inc. Galvani Bioelectronics Ltd. Medicxi Ventures Moderna Inc. Vaxcyte Inc. covid-19 cov19pol cov19count Moncef...
BioCentury | Jul 10, 2020
Finance

Nkarta’s $252M IPO among biggest preclinical listings ever

...preclinical biotechs that have raised at least $225 million in IPOs have included vaccine developer VaxCyte Inc....
BioCentury | Jun 13, 2020
Finance

With nearly $1B raised overnight, quartet of offerings underscore demand for biotech IPOs

...Its stock gained $8.13 (50%) to $24.63 Friday, bringing its market cap to $2.5 billion. Vaxcyte Inc....
...S. Eaton, Staff Writer Avidity Biosciences Inc. Generation Bio Co. Lantern Pharma Inc. Burning Rock Biotech Ltd. Simcere Pharmaceutical Group Ltd. Vaxcyte Inc. IPO...
BioCentury | Jun 9, 2020
Finance

Next up on NASDAQ: trio of preclinical companies ready for debuts, plus new filings

...a continued appetite for fresh biopharma paper. Gene therapy company Generation Bio Co., vaccines play Vaxcyte Inc....
...Corp. Lantern Pharma Inc. Akouos Inc. Fusion Pharmaceuticals Inc. PolyPid Ltd. Avidity Biosciences Inc. Burning Rock Biotech Ltd. Genetron Holdings Ltd. Royalty Pharma plc Vaxcyte Inc. Legend...
BioCentury | Jun 3, 2020
Finance

Daily Chart: IPO queue grows to 20 life sciences companies

...Ltd. SCM Lifescience Aptamer Sciences Inc. Immunotech Biopharm Ltd. Applied Molecular Transport Inc. Avidity Biosciences Inc. Burning Rock Biotech Ltd. Royalty Pharma plc Vaxcyte Inc. Ocumension...
BioCentury | May 25, 2020
Finance

New additions to the IPO queue: Generation Bio, Avidity, Vaxcyte and more

...Co., antibody-oligonucleotide conjugate developer Avidity Biosciences Inc. and vaccine company Vaxcyte Inc., which was known as SutroVax...
...Sciences Acquisition Corp. II, a blank-check company backed by Perceptive Advisors. Paul Bonanos, Associate Editor Generation Bio Co. Vaxcyte Inc. Applied...
BioCentury | May 6, 2020
Management Tracks

Mendel named GenMark’s CEO; plus SutroVax, Illumina, Arrowhead, Tessa and more

...The diagnostic company’s PCR-based SARS-CoV-2 test was granted Emergency Use Authorization by FDA in March. SutroVax...
...in a March series D to bring its 24-valent pneumonia vaccine to the clinic (see “SutroVax...
...Chisholm as non-executive chairman. He was chairman of Genomics England Ltd. Robin Sawka, BioCentury Staff GenMark Diagnostics Inc. Vaxcyte Inc. Illumina...
BioCentury | Apr 23, 2020
Finance

Crossovers back Affinivax in $120M series B to broaden clinical vaccine pipeline

...looking for disruptive technologies.” Another potential Prevnar 13 competitor with a broad-spectrum pneumococcal vaccine candidate, SutroVax...
Items per page:
1 - 10 of 30
BioCentury | Mar 25, 2021
Management Tracks

Slaoui resigns from Vaxcyte, Centessa; plus moves at HHS, Fate, Inotrem, Immuneering, SwanBio and more

...sexual harassment allegations, former Operation Warp Speed leader Moncef Slaoui has resigned as chairman of Vaxcyte Inc....
...Services Fate Therapeutics Inc. Cue Health Inc. Inotrem S.A. Harpoon Therapeutics Inc. MatriSys Bioscience Inc. Immuneering Corp. SiteOne Therapeutics Inc. Follicum AB Centessa Pharmaceuticals Ltd. Vaxcyte Inc....
BioCentury | Mar 25, 2021
Management Tracks

Slaoui stepping back from all biopharma roles, expresses ‘deep regrets’ following sexual harassment claim

...years, is a partner at Medicxi and chairman of Medicxi portfolio companies Divide & Conquer and Vaxcyte Inc....
BioCentury | Jan 22, 2021
Product Development

Slaoui on Warp Speed’s successes, limitations and lessons

...in 2016 by GSK and Verily Life Sciences to develop and commercialize bioelectronic medicines, and SutroVax...
...to have platform trials running as quickly as possible. Steve Usdin GlaxoSmithKline plc Pfizer Inc. Galvani Bioelectronics Ltd. Medicxi Ventures Moderna Inc. Vaxcyte Inc. covid-19 cov19pol cov19count Moncef...
BioCentury | Jul 10, 2020
Finance

Nkarta’s $252M IPO among biggest preclinical listings ever

...preclinical biotechs that have raised at least $225 million in IPOs have included vaccine developer VaxCyte Inc....
BioCentury | Jun 13, 2020
Finance

With nearly $1B raised overnight, quartet of offerings underscore demand for biotech IPOs

...Its stock gained $8.13 (50%) to $24.63 Friday, bringing its market cap to $2.5 billion. Vaxcyte Inc....
...S. Eaton, Staff Writer Avidity Biosciences Inc. Generation Bio Co. Lantern Pharma Inc. Burning Rock Biotech Ltd. Simcere Pharmaceutical Group Ltd. Vaxcyte Inc. IPO...
BioCentury | Jun 9, 2020
Finance

Next up on NASDAQ: trio of preclinical companies ready for debuts, plus new filings

...a continued appetite for fresh biopharma paper. Gene therapy company Generation Bio Co., vaccines play Vaxcyte Inc....
...Corp. Lantern Pharma Inc. Akouos Inc. Fusion Pharmaceuticals Inc. PolyPid Ltd. Avidity Biosciences Inc. Burning Rock Biotech Ltd. Genetron Holdings Ltd. Royalty Pharma plc Vaxcyte Inc. Legend...
BioCentury | Jun 3, 2020
Finance

Daily Chart: IPO queue grows to 20 life sciences companies

...Ltd. SCM Lifescience Aptamer Sciences Inc. Immunotech Biopharm Ltd. Applied Molecular Transport Inc. Avidity Biosciences Inc. Burning Rock Biotech Ltd. Royalty Pharma plc Vaxcyte Inc. Ocumension...
BioCentury | May 25, 2020
Finance

New additions to the IPO queue: Generation Bio, Avidity, Vaxcyte and more

...Co., antibody-oligonucleotide conjugate developer Avidity Biosciences Inc. and vaccine company Vaxcyte Inc., which was known as SutroVax...
...Sciences Acquisition Corp. II, a blank-check company backed by Perceptive Advisors. Paul Bonanos, Associate Editor Generation Bio Co. Vaxcyte Inc. Applied...
BioCentury | May 6, 2020
Management Tracks

Mendel named GenMark’s CEO; plus SutroVax, Illumina, Arrowhead, Tessa and more

...The diagnostic company’s PCR-based SARS-CoV-2 test was granted Emergency Use Authorization by FDA in March. SutroVax...
...in a March series D to bring its 24-valent pneumonia vaccine to the clinic (see “SutroVax...
...Chisholm as non-executive chairman. He was chairman of Genomics England Ltd. Robin Sawka, BioCentury Staff GenMark Diagnostics Inc. Vaxcyte Inc. Illumina...
BioCentury | Apr 23, 2020
Finance

Crossovers back Affinivax in $120M series B to broaden clinical vaccine pipeline

...looking for disruptive technologies.” Another potential Prevnar 13 competitor with a broad-spectrum pneumococcal vaccine candidate, SutroVax...
Items per page:
1 - 10 of 30